Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
08/2005
08/09/2005CA2142086C Wheat flour and process for producing the same
08/09/2005CA2019676C Particle-mediated transformation of animal somatic cells
08/09/2005CA2012778C Disease-resistant transgenic plants
08/04/2005WO2005071411A1 Methods for the identification of inhibitors of adenylosuccinate synthase and cyclic nucleotide phosphodiesterase as antibiotics
08/04/2005WO2005071107A1 A141s and g399s mutation in the omi/htra2 protein in parkinson's disease
08/04/2005WO2005071094A2 Method for producing l-threonine using recombinant enterobacteriaceae with incre ased enolase activity
08/04/2005WO2005071087A1 Method for producing carotenoids and bacteria used therefor
08/04/2005WO2005071086A1 Method for the genetic modulation of the biosynthesis of hemicelluloses, cellulose and uronic acids in plant cells using gene expression cassettes
08/04/2005WO2005071073A1 Fap compositions and the use thereof for immunomodulation
08/04/2005WO2005071072A1 The recombinant murine leukemia virus reverse transcriptase, the gene encoding it and the method for expressing it
08/04/2005WO2005071071A1 Ptd-human choline acetyltransferase fusion protein and its application
08/04/2005WO2005071070A2 Substances directed against specific sequence essential for heparanase catalytic activity end uses thereof as heparanase inhibitors
08/04/2005WO2005070957A1 Hcv rna-dependent rna polymerase
08/04/2005WO2005070468A2 Transglutaminase mediated conjugation of peptides
08/04/2005WO2005070457A1 Melphalan prodrugs
08/04/2005WO2005070180A2 Coccidian parasite casein kinase i as a chemotherapeutic target for antiprotozoal agents
08/04/2005WO2005069994A2 Folate conjugates and complexes
08/04/2005WO2005069921A2 H. pylori fucosyltransferases
08/04/2005WO2005061532A8 Pathogenic infection detection compositions and methods
08/04/2005WO2005051990A3 Polynucleotides overexpressed in breast cancer cells, compositions and methods for the therapy and diagnosis of breast cancer
08/04/2005WO2005044859A3 Cd20 antibodies with increased fc receptor binding affinity and effector function
08/04/2005WO2005044849A3 Lp mammalian proteins; related reagents
08/04/2005WO2004078953A9 Translocating enzyme used as a selection marker
08/04/2005WO2004072240A3 Antiplasmin cleaving enzyme
08/04/2005WO2004055158A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/04/2005WO2004035170A3 Composition for separating molecules
08/04/2005WO2004003169A3 Recombinant genes for polyketide modifying enzymes
08/04/2005WO2003062173A3 Alanine 2,3- aminomutase
08/04/2005US20050172363 Nematode PPPT-like sequences
08/04/2005US20050172354 Expression vector comprising nucleotide sequences coding isoflavone 3'-hydroxylase; for identifying modulators of insect growth; biological pest control; insect resistance
08/04/2005US20050172352 Using presence of allelic mutation in protein kinase c gene as diagnostic indication of heart disease
08/04/2005US20050172350 Identifying modulators of purine/pyrimidine phosphoribosyl transferase (PPPT) polypeptides; treating and preventing microorganismal infection in crop plants
08/04/2005US20050172348 models can be used to improve diagnosis of diseases relating to energy metabolism as well as identifying and testing pharmaceutical compositions for better treatment and prevention of diseases relating to energy metabolism; transgenic mouse has an elevated glycogen content in skeletal muscle
08/04/2005US20050171333 Lithium chloride/bromide, alcohol (ethanol/methanol), and trisodium citrate; solid phase synthesis; deoxyribonucleases
08/04/2005US20050171059 Silanol enzyme inhibitors
08/04/2005US20050171012 Preventives/remedies for bone/joint diseases
08/04/2005US20050170500 Methods for identifying risk of melanoma and treatments thereof
08/04/2005US20050170489 Beta-secretase enzyme compositions and methods
08/04/2005US20050170488 Multiply-substituted protease variants
08/04/2005US20050170487 Generating/designing hydrolase mutants for use in detergents, papermaking and textile treatment
08/04/2005US20050170486 Nucleic acids encoding human inositolpolyphosphate 5-phosphatase
08/04/2005US20050170481 Novel (d)-2-hydroxy-acid oxidase derived from microorganism and biochemical process for producing glyoxylic acid therewith
08/04/2005US20050170480 Transgenic microbial polyhydroxyalkanoate producers
08/04/2005US20050170478 Expression of phospholipid:diacylglycerine acyltranssferase (pdat) for the production of plant storage lipids with polyunsaturated fatty acids
08/04/2005US20050170471 Enzyme multimer and process of producing same
08/04/2005US20050170469 Hyaluronate synthase gene and uses thereof
08/04/2005US20050170467 Nucleic acid sequences for polypeptides that inhibit endothelial cell growth; PRO Polypeptides; homology to Fibroblast Growth Factor-8 (FGF-8); vectors, host cells, primers and probes
08/04/2005US20050170465 Nucleotide sequences coding transport proteins for identifying modulators for prevention and treatment of cell proliferative, nervous system, skin and inflammatory disorders
08/04/2005US20050170460 Method for diversifying the chemical composition of proteins produced in vivo by genetically disabling the editing function of their aminoacyl tRNA synthetases
08/04/2005US20050170458 Inhibiting endothelial cell growth
08/04/2005US20050170457 Novel recombinant proteins with N-terminal free thiol
08/04/2005US20050170454 Cell culture medium
08/04/2005US20050170452 Method to engineer mammanlian-type carbohydrate structures
08/04/2005US20050170449 Soluble GlcNAc phosphotransferase
08/04/2005US20050170434 Modulators of lymphocyte activation, mkk3b compositions and methods of use
08/04/2005US20050170431 PYK2 crystal structure and uses
08/04/2005US20050170419 peptide of given amino acid sequence related to the omega-hydroxylase cytochrome P450 drug-metabolizing enzyme subfamily; use drug screening
08/04/2005US20050170415 Serine protease BSSP6
08/04/2005US20050170411 Genes and proteins involved in the biosynthesis of enediyne ring structures
08/04/2005US20050170396 Using monoclonal antibodies to determine concentration of preferential membrane bound receptor in cancer cells; immunoassay
08/04/2005US20050170395 Novel human proteases and polynucleotides encoding the same
08/04/2005US20050170381 Using lymphocytes expressing jun kinase as tools in detecting modulators for treatment of cell proliferative disorders
08/04/2005US20050170374 Expression vector comprising nucleotide sequences coding protein factor for treatment, diagnosis and prevention of proliferative and differentiative disorders
08/04/2005US20050170365 Nucleotide sequences coding modified deoxyribonuclease for treatment of pulmonary, autoimmune and/or cystic fibrosis
08/04/2005US20050170364 Novel human kinase protein and polynucleotides encoding the same
08/04/2005US20050170349 A purified polypeptide comprising a splice variant of AMP-activated kinase; a nucleic acid and expression vector; bioassay for modulators; antibodies for the polypeptide; improved metabolic regulation
08/04/2005US20050170348 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
08/04/2005US20050169937 Attacking immune tolerant species; having at least one consensus amino acid sequence
08/04/2005US20050169913 Administering a monoclonal antibody or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss; inhibiting gene expression of prothrombinase
08/04/2005US20050169907 amino acid sequence peptide is derived from the N' terminus region of the 50 Kd subunit of heparanase; used in drug screening for antibody as enzyme inhibitors; antitumor agents, anticarcinogenic agents, antiinflammatory agents; autoimmune disease and kidney urogenital disorder
08/04/2005US20050169906 Modified human acid spingomyelinase having increased activity, and methods for making the same
08/04/2005US20050169905 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
08/04/2005CA2553221A1 Folate conjugates and complexes
08/04/2005CA2552063A1 Method for producing carotenoids and bacteria used therefor
08/04/2005CA2552043A1 Transglutaminase mediated conjugation of peptides
08/03/2005EP1559788A1 Use lipase for improving doughs and baked products
08/03/2005EP1559787A1 Cold-resistant pyruvate phosphate dikinase.
08/03/2005EP1559781A1 Method of detecting bone paget's disease
08/03/2005EP1559779A1 Modified inosine monophosphate dehydrogenases
08/03/2005EP1559776A2 Non-toxic, non-toxigenic, non-pathogenic Fusarium expression system and promoters and terminators for use therein
08/03/2005EP1559722A1 Caenorhabditis elegans p21-activated kinase (PAK) gene and associated loss-of-function phenotypes
08/03/2005EP1558753A2 Spleen tyrosine kinase catalytic domain: crystal structure and binding pockets thereof
08/03/2005EP1558751A2 Crystal structure of pim-1 kinase
08/03/2005EP1558747A2 Glycoprotein synthesis
08/03/2005EP1558739A1 Plant alpha farnesene synthase and polynucleotides encoding same
08/03/2005EP1558738A2 Methods for regulating plant gaba production
08/03/2005EP1558736A1 A method of modulating epithelial cell activity by modulating the functional levels of sphingosine kinase
08/03/2005EP1558733A2 Improved crosslinked enzyme aggregates
08/03/2005EP1558732A1 Method and system for creating a library of crosslinked enzyme aggregates
08/03/2005EP1558731A2 Modified hepsin molecules having a substitute activation sequence and uses thereof
08/03/2005EP1558730A1 Inhibitor-resistant hcv ns3 protease
08/03/2005EP1558729A2 Rapidly degraded reporter fusion proteins
08/03/2005EP1558728A2 Methods to identify agents modulating functions of polypeptide galnac-transferases, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
08/03/2005EP1558201A2 Novel compositions with chitinase activity
08/03/2005EP1379639B1 Mouse glucuronyl c5-epimerase, dna encoding the same and use thereof
08/03/2005EP1330166B1 Food grade transglutaminase inhibitor and uses thereof
08/03/2005EP1237900A4 Subunit optimized fusion proteins
08/03/2005EP1165806B1 Phosphatases with improved phytase activity
08/03/2005EP1158052B1 Beta-primeverosidase gene
08/03/2005EP1140173B1 Vascular endothelial cell growth factor antagonists and uses thereof
1 ... 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 ... 1416